Henrik C. Hansen

Dr. Hansen is Senior Vice President of Operations at Zenith. He is responsible for Zenith’s intellectual property portfolio, new technology, and execution of strategic procedures to achieve corporate objectives. Henrik brings over 22 years of biotechnology experience from both academia and industry in basic research to drug discovery development. His areas of expertise include medicinal chemistry, carbohydrate chemistry, high throughput synthesis, process development, and manufacturing of drug substances and drug products under Good Manufacturing Practices (GMPs) for clinical use.

Dr. Hansen holds an M.Sc. in Chemical Engineering from the Technical University of Denmark and a Ph.D. in Organic Chemistry from Lund University, Sweden. He has authored or co-authored more than 75 articles and meeting abstracts and is listed as an inventor of 12 patent families.